Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial

Home, Philip D.; Lam, Raymond L. H.; Carofano, Wendy L.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rosenstock, Julio; Hollander, Priscilla A.; Gallwitz, Baptist

dc.contributor.author	Gallwitz, Baptist
dc.date.accessioned	2019-08-13T07:55:53Z
dc.date.available	2019-08-13T07:55:53Z
dc.date.issued	2018
dc.identifier.issn	1463-1326
dc.identifier.uri	http://hdl.handle.net/10900/91377
dc.language.iso	en	de_DE
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.13354
dc.subject.ddc	610	de_DE
dc.title	Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_01436
utue.publikation.seiten	2220-2228	de_DE
utue.personen.roh	Home, Philip D.
utue.personen.roh	Lam, Raymond L. H.
utue.personen.roh	Carofano, Wendy L.
utue.personen.roh	Golm, Gregory T.
utue.personen.roh	Eldor, Roy
utue.personen.roh	Crutchlow, Michael F.
utue.personen.roh	Marcos, Michael C.
utue.personen.roh	Rosenstock, Julio
utue.personen.roh	Hollander, Priscilla A.
utue.personen.roh	Gallwitz, Baptist
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	20	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)